OLBA HEALTHCARE HOLDINGS, Inc. (2689) AI Stock Analysis

• Market Cap: ¥12.34B
• Dividend Yield: 3.95%
• Average Volume (3M): 3.73K
• Price to Earnings (P/E): 8.4
• Beta (1Y): 0.27
• Revenue Growth: 3.49%
• EPS Growth: -4.39%
• Country: JP
• Employees: 1,354
• Sector: Healthcare
• Sector Strength: 47
• Industry: Medical - Distribution
• EPS (TTM): 83.95
• Shares Outstanding: 6,250,000
• 10 Day Avg. Volume: 1,980
• 30 Day Avg. Volume: 3,730
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥2,377.00
• Price Target Upside: 17.21% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 68 Neutral
• Price Target: ¥2,205.00 ▲(8.73% Upside)

OLBA HEALTHCARE HOLDINGS, Inc. has a solid financial performance with strong revenue growth and a stable balance sheet. The valuation is attractive due to a low P/E ratio and a high dividend yield. However, technical indicators suggest weak market momentum, which could pose short-term challenges. The absence of earnings call data and corporate events limits additional insights.

OLBA HEALTHCARE HOLDINGS, Inc. Business Overview & Revenue Model

Company Description

OLBA HEALTHCARE HOLDINGS, Inc. (2689) is a healthcare company focused on providing innovative medical solutions and services across various sectors, including pharmaceuticals, medical devices, and healthcare technology. The company aims to enhance patient outcomes through its diverse portfolio of products and services, which include the development and distribution of prescription medications, over-the-counter products, and advanced medical devices that cater to both healthcare providers and patients.

How the Company Makes Money

OLBA HEALTHCARE HOLDINGS generates revenue through multiple streams, primarily from the sale of its pharmaceutical products and medical devices. The company has established partnerships with healthcare providers, hospitals, and pharmacies, allowing it to distribute its offerings widely. Additionally, OLBA may engage in research and development collaborations with other firms to innovate and bring new products to market, which can lead to licensing and royalty agreements that contribute to its revenue. The company's ability to leverage its technological advancements and maintain strong relationships within the healthcare ecosystem is crucial for sustaining its earnings.

OLBA HEALTHCARE HOLDINGS, Inc. Financial Statement Overview

Summary

OLBA HEALTHCARE HOLDINGS, Inc. demonstrates solid financial performance with consistent revenue growth and strong cash flow generation. The company maintains low debt levels, enhancing financial stability. Profitability margins are stable, with potential for improvement.

Income Statement

OLBA HEALTHCARE HOLDINGS, Inc. has demonstrated consistent revenue growth with a 7.33% increase from 2023 to 2024. The gross profit margin stands at 11.47%, and the net profit margin is 1.27%, indicating stable profitability. The EBIT margin is 1.88%, and the EBITDA margin is 2.38%, reflecting efficient operations, although there is room for improvement in profitability.

Balance Sheet

The company's balance sheet shows a strong equity position with an equity ratio of 26.30%. The debt-to-equity ratio is 0.14, indicating low leverage and financial stability. Return on equity is 13.19%, showcasing effective use of equity to generate profits.

Cash Flow

OLBA HEALTHCARE HOLDINGS, Inc. has shown a significant improvement in free cash flow, with a positive free cash flow of 1.61 billion yen in 2024, compared to a negative free cash flow in 2023. The operating cash flow to net income ratio is 1.39, indicating strong cash generation relative to net income.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	121.64B	122.70B	118.56B	110.47B	107.96B	112.98B
Gross Profit	13.73B	13.91B	13.60B	12.95B	12.50B	11.60B
EBITDA	2.47B	2.59B	2.83B	2.68B	2.56B	1.94B
Net Income	1.32B	1.43B	1.50B	1.41B	1.54B	989.37M
Balance Sheet
Total Assets	47.02B	45.87B	43.24B	40.88B	39.97B	36.56B
Cash, Cash Equivalents and Short-Term Investments	2.98B	3.47B	2.73B	2.40B	3.19B	2.16B
Total Debt	3.70B	2.95B	1.63B	1.92B	1.28B	1.96B
Total Liabilities	35.24B	33.56B	31.86B	30.55B	30.88B	28.43B
Stockholders Equity	11.77B	12.26B	11.37B	10.33B	9.09B	8.13B
Cash Flow
Free Cash Flow	0.00	181.25M	1.61B	-910.52M	1.97B	2.49B
Operating Cash Flow	0.00	1.63B	2.08B	-659.52M	2.42B	3.13B
Investing Cash Flow	0.00	-1.64B	-673.03M	-306.25M	-211.81M	-630.38M
Financing Cash Flow	0.00	686.95M	-1.09B	175.94M	-1.17B	-2.26B

OLBA HEALTHCARE HOLDINGS, Inc. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 2028.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2689, the sentiment is Negative. The current price of 2028 is below the 20-day moving average (MA) of 2040.90, below the 50-day MA of 2036.41, and above the 200-day MA of 1993.71, indicating a neutral trend. The MACD of -4.14 indicates Positive momentum. The RSI at 46.31 is Neutral, neither overbought nor oversold. The STOCH value of 40.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:2689.

OLBA HEALTHCARE HOLDINGS, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
9265	76 Outperform	¥7.93B	12.45		1.98%	4.76%	9.55%
3417	75 Outperform	¥17.52B	6.12		1.92%	3.70%	37.00%
3151	73 Outperform	¥55.97B	8.66		3.61%	2.22%	21.19%
4350	70 Outperform	¥14.49B	11.99		2.54%	5.93%	-36.11%
3183	70 Outperform	¥38.70B	18.33		3.87%	5.81%	8.10%
2689	68 Neutral	¥12.34B	8.38		3.95%	3.49%	-4.39%
Sector *	51 Neutral	$7.81B	-0.22	-40.01%	2.29%	21.48%	-2.11%

OLBA HEALTHCARE HOLDINGS, Inc. Corporate Events

OLBA HEALTHCARE Reports Modest Sales Growth Amid Profit Decline

OLBA HEALTHCARE HOLDINGS, Inc. reported a modest increase in net sales for the nine months ending March 31, 2025, despite a decline in operating and ordinary profits compared to the previous year. The company’s financial position shows a slight increase in total assets and net assets, although the equity ratio decreased. The announcement indicates a stable dividend forecast, with no revisions to the financial results forecast, suggesting a cautious but steady approach to growth and shareholder returns.